Adequacy of access to investigative drugs for seriously ill patients
United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.
Allegations of FDA abuses of authority
Blood safety and availability
Competition in the cellular telephone service industry
Department of Energy's Hanford Spent Nuclear Fuel project
Imported drugs
Medicaid fraud and abuse
Review of the Department of Energy's Hanford radioactive tank waste privatization contract
Security at the Department of Energy's laboratories
The Department of Energy's funding of Molten Metal Technology
The Department of Health and Human Services' policy for federal workplace drug testing programs
The Olympics site selection process
Whistleblowers at Department of Energy facilities
Worker safety at DOE nuclear facilities
